For us at AOP Orphan, partnerships can go different ways: as a partner for pharmaceutical companies that wish to place their product in AOP Orphan’s core markets, as a licensor for in-house developments that will be distributed by partners in other countries, as well as a partner in joint development projects.
AOP Orphan masters the intricacies of doing business in the markets of Europe and the Middle East.
Legal requirements, market access experience, healthcare system, mentality, and culture are so different that a superficial knowledge of the market is not enough. Therefore, AOP Orphan is present in each of its core markets with its own team to handle these challenges appropriately.
For us at AOP Orphan, in-licensing means obtaining exclusive marketing rights for a product in a specific region – preferably in the core markets of Austria, Germany, Poland, the Czech Republic, Slovakia, Hungary, Romania, the United Kingdom, the Baltic states, Bulgaria, Scandinavia, France, and the Middle East.